Overview

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate if treatment with an anticoagulant drug increases birth weight in pregnancies complicated by fetal growth restriction.
Phase:
Phase 4
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Aarhus University Hospital
LEO Pharma
Treatments:
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin